Timothy Stremmel
Podiatrist · Anniston, ALNPI 1750389649
Payments from drug & device makers
What this record shows
17 manufacturers reported payments, led by Pylant Medical at 46.0% of the total. Reporting peaked in 2019 at $1,170 and has fallen 61.0% since, to $456 in 2025.
Across 54 payments — averaging $44.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$1K
- Organogenesis Inc.$524
- Paratek Pharmaceuticals, Inc.$130
- Mimedx Group, Inc.$100
- Amniox Medical, Inc.$100
- Musculoskeletal Transplant Foundation Inc.$73
- plus $380 from 11 others
What the payments were for
- Food & beverage$1,30754%
- Education$1,11546%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 1 | $1,115 |
| Organogenesis Inc. | 22 | $524 |
| Paratek Pharmaceuticals, Inc. | 8 | $130 |
| Mimedx Group, Inc. | 4 | $100 |
| Amniox Medical, Inc. | 1 | $100 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $73 |
| Stryker | 1 | $69 |
| Globus Medical | 2 | $61 |
| Kerecis Limited | 2 | $56 |
| Nevro Corp. | 2 | $41 |
| Boston Scientific | 2 | $40 |
| Medtronic | 3 | $39 |
| Convatec Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $21 |
| Amgen | 1 | $14 |
| Reprise Biomedical, Inc. | 1 | $10 |
| Orthofix Medical, Inc. | 1 | $5 |
How this compares
$2,422 in reported general payments places this provider in the 75th percentile of 59 podiatrist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 121 | $1,037 |
| CiclopiroxCiclopirox Olamine | 27 | $769 |
| Mupirocin | 60 | $737 |
| Betamethasone Dipropionate | 14 | $649 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $169 |
| Gabapentin | 12 | $161 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Anniston
- Michael HamesFlorence$100K
- James MorganMobile$21K
- John RobersonBirmingham$10K
- Kyle MaukBirmingham$10K
- Johnnie AlstonMontgomery$9K
- Heidi ChristieMontgomery$7K
- Brent HaverstockBirmingham$7K
- David LindeBirmingham$6K
- Robert OcampoCullman$5K
- Jamie ClecklerBirmingham$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.